AVITA Medical, Inc. (RCEL)
15.68
-0.64
(-3.92%)
USD |
NASDAQ |
Nov 05, 16:00
16.52
+0.84
(+5.36%)
After-Hours: 20:00
AVITA Medical Net Income (TTM) : -43.08M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.08M |
| March 31, 2026 | -45.34M |
| December 31, 2025 | -48.59M |
| September 30, 2025 | -48.56M |
| June 30, 2025 | -51.57M |
| March 31, 2025 | -57.05M |
| December 31, 2024 | -61.84M |
| September 30, 2024 | -57.32M |
| June 30, 2024 | -49.83M |
| March 31, 2024 | -44.82M |
| Date | Value |
|---|---|
| December 31, 2023 | -35.38M |
| September 30, 2023 | -33.67M |
| June 30, 2023 | -30.54M |
| March 31, 2023 | -26.42M |
| December 31, 2022 | -26.66M |
| September 30, 2022 | -26.03M |
| June 30, 2022 | -26.44M |
| March 31, 2022 | -25.82M |
| June 30, 2021 | -26.58M |
| March 31, 2021 | -34.78M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Iovance Biotherapeutics, Inc. | -- |
| Halozyme Therapeutics, Inc. | 413.60M |
| Agenus, Inc. | 91.94M |
| Amgen, Inc. | 9.391B |
| Fate Therapeutics, Inc. | -126.00M |